Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.
about
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.The role of angiogenesis in human non-Hodgkin lymphomas.Management of indolent lymphoma: where are we now and where are we going.Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphomaImmunomodulating antibodies and drugs for the treatment of hematological malignancies.Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity.Lenalidomide in lymphomas and chronic lymphocytic leukemia.Therapeutic effects of thalidomide in hematologic disorders: a review.Rethinking clinical response and outcome assessment in a biologic age.Cereblon in health and disease.t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement.
P2860
Q36612613-9701F47B-4014-482B-823D-D59DDB5E020EQ36670881-2A8079A7-339B-4A67-A670-FA8CD9A18DB0Q36784860-BEE51B90-DD54-494D-BF94-B52325E93577Q37321798-0E9E2DE4-043F-4D5B-8DF2-7F82418E4FA6Q37832694-C93051A1-9B3B-48F4-958C-C7BC803B75BBQ37938966-A8640D27-FFD8-429A-94BA-D2DC9CB591B2Q38077277-A0D7F7E9-B3B5-427C-B25D-44C8A2268795Q38121762-1BBECFE7-BB64-4835-B0C3-FD75471E1361Q38480777-3AF76C7A-60CF-4A73-B3D0-345E3704A04CQ38876495-BBFCE02C-D9DC-40FE-86BF-69191C16AA7CQ54379460-04489BBE-405D-4220-991A-1BB430C592ED
P2860
Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Thalidomide has limited single ...... e Cancer and Leukemia Group B.
@en
Thalidomide has limited single ...... e Cancer and Leukemia Group B.
@nl
type
label
Thalidomide has limited single ...... e Cancer and Leukemia Group B.
@en
Thalidomide has limited single ...... e Cancer and Leukemia Group B.
@nl
prefLabel
Thalidomide has limited single ...... e Cancer and Leukemia Group B.
@en
Thalidomide has limited single ...... e Cancer and Leukemia Group B.
@nl
P2093
P2860
P1476
Thalidomide has limited single ...... e Cancer and Leukemia Group B.
@en
P2093
Bruce D Cheson
David Grinblatt
David Rizzieri
Donna Niedzwiecki
Jeffrey L Johnson
Nancy L Bartlett
Sonali M Smith
P2860
P304
P356
10.1111/J.1365-2141.2007.06937.X
P407
P577
2008-02-01T00:00:00Z